Axe Compute

Axe Compute Cash Flow per Share

The Operating Cash Flow per Share of Axe Compute (AGPU) as of Oct 30, 2026 is -0.47 USD. In the previous year, Operating Cash Flow per Share was -2.19 USD — a change of -78.56% (higher).

Cash Flow per Share

-0.47USD

YoY

-78.56%

Last updated:

Operating Cash Flow per Share of Axe Compute is 2025 -0.47 USD. Operating Cash Flow per Share of Axe Compute was 2024 -2.19 USD. It decreases by -78.56% higher compared to the previous year.

The Axe Compute Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-79.76 USD
Jan 1, 2019
-55.51 USD
Jan 1, 2020
-13.62 USD
Jan 1, 2021
-3.72 USD
Jan 1, 2022
-3.14 USD
Jan 1, 2023
-3.25 USD
Jan 1, 2024
-2.19 USD
Jan 1, 2025
-0.47 USD
The Axe Compute Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.47USD-78.56%
-2.19USD-32.47%
-3.25USD+3.30%
-3.14USD-15.46%
-3.72USD-72.72%
-13.62USD-75.46%
-55.51USD-30.40%
-79.76USD-44.20%
-142.94USD-25.94%
-193.01USD-62.36%
-512.83USD+36.90%
-374.60USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axe Compute Stock analysis

What does Axe Compute do? Predictive Oncology, Inc. generates revenue through its subsidiaries Helomics Holding Corporation and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies, offering CLIA-certified clinical testing for oncologists. Skyline Medical Inc. markets the STREAMWAY System, which automates medical fluid disposal, targeting hospitals and clinics globally. The company's products serve healthcare providers seeking advanced diagnostic and waste management solutions. Helomics focuses on personalized cancer treatment decisions using AI-driven analysis, while Skyline Medical Inc. provides automated fluid disposal systems. The STREAMWAY System is sold through domestic and international divisions to medical facilities requiring efficient waste handling. TumorGenesis Inc. supports laboratory-based tumor research, complementing Helomics' clinical offerings. The company's revenue streams include AI-based therapy personalization services and the STREAMWAY System sales. Healthcare providers, including oncologists and medical facilities, purchase these products to enhance treatment precision and operational efficiency. Subsidiaries operate under the parent company's structure, with Helomics handling AI applications and Skyline Medical managing medical device distribution. Axe Compute is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axe Compute stock

Operating Cash Flow per Share of Axe Compute is -0.47 USD in 2025.

Operating Cash Flow per Share of Axe Compute changed from -2.19 USD to -0.47 USD, representing a -78.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Axe Compute since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Axe Compute

All Key Metrics — Axe Compute